Bicycle Therapeutics Ltd
Ownership
Ownership Structure
Who owns Bicycle Therapeutics Ltd (BCYC)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 15.3% of the shares are freely tradable; institutional investors hold 71.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Baker Bros Advisors LP | 15.55 | 10,885,357 | +0.0 | 06/30/2026 |
| FCPM III SERVICES BV | 4.96 | 3,468,430 | +0.0 | 06/30/2026 |
| Armistice Capital, LLC | 4.85 | 3,398,000 | +0.0 | 06/30/2026 |
| Long Focus Capital Management, LLC | 4.73 | 3,310,687 | +0.0 | 06/30/2026 |
| Acadian Asset Management LLC | 2.81 | 1,968,025 | +0.0 | 06/30/2026 |
| Renaissance Technologies Corp | 2.19 | 1,533,400 | +56.6 | 06/30/2026 |
| GSK PLC | 2.19 | 1,529,561 | +0.0 | 06/30/2026 |
| T. Rowe Price Associates, Inc. | 1.29 | 902,150 | -12.3 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 1.14 | 797,940 | +111.5 | 06/30/2026 |
| Qube Research & Technologies | 1.11 | 775,567 | +151.3 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Lee Kevin | CHIEF EXECUTIVE OFFICER | 595,866 | 2,085,531 $ | Oct 5, 2026 | direct |
| Skynner Michael | CHIEF SCIENTIFIC OFFICER | 154,726 | 541,541 $ | Oct 5, 2026 | direct |
| Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | 92,561 | 323,964 $ | Oct 5, 2026 | direct |
| Perry Jennifer Scott | Chief Operating Officer | 89,552 | 313,432 $ | Oct 5, 2026 | direct |
| Thompson Travis Alvin | Chief Financial Officer | 64,449 | 225,572 $ | Oct 5, 2026 | direct |
| Swanton Robert Charles | Director | 15,782 | 55,237 $ | Oct 2, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Perry Jennifer Scott | Chief Operating Officer | Sell | 326 | 3.78 | 1,232 |
| Oct 5, 2026 | Perry Jennifer Scott | Chief Operating Officer | Sell | 80 | 3.56 | 285 |
| Oct 5, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 242 | 3.57 | 864 |
| Oct 5, 2026 | Thompson Travis Alvin | Chief Financial Officer | Sell | 79 | 3.57 | 282 |
| Oct 5, 2026 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 1,638 | 3.57 | 5,848 |
| Oct 5, 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sell | 503 | 3.57 | 1,796 |
| Oct 2, 2026 | Perry Jennifer Scott | Chief Operating Officer | Sell | 1,094 | 3.47 | 3,796 |
| Oct 2, 2026 | Swanton Robert Charles | Director | Sell | 3,431 | 3.47 | 11,906 |
| Oct 2, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | 1,572 | 3.47 | 5,455 |
| Oct 2, 2026 | Thompson Travis Alvin | Chief Financial Officer | Sell | 893 | 3.47 | 3,099 |
| Oct 2, 2026 | Lee Kevin | CHIEF EXECUTIVE OFFICER | Sell | 6,167 | 3.47 | 21,399 |
| Oct 2, 2026 | Skynner Michael | CHIEF SCIENTIFIC OFFICER | Sell | 1,942 | 3.47 | 6,739 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.